Indian generic drugmakers such as Sun Pharma, Cipla, Dr Reddy's and Lupin are beginning to develop their own versions of Novo Nordisk's blockbuster weight-loss drug Wegovy. Some analysts predict the weight-loss drug market could reach $100 billion annually by 2030 as obesity rates rise globally. Novo Nordisk has been unable...
India’s Biocon Approved for the First Generic Version of liraglutide Injectible
Headquartered in Bangalore, Biocon Ltd, a leading Indian pharmaceutical company, is positioning itself in the weight loss drug market as patents for some blockbuster obesity medications are set to expire. The company has secured approval from the UK's regulatory authority for the first generic version of liraglutide, an injectable drug...